Evaluation of the Adherence and the Patient Acceptability of Zomacton Treatment With the Zomajet Vision X Device

Trial Profile

Evaluation of the Adherence and the Patient Acceptability of Zomacton Treatment With the Zomajet Vision X Device

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 15 May 2015

At a glance

  • Drugs Somatropin (Primary)
  • Indications Somatotropin deficiency; Turner's syndrome
  • Focus Therapeutic Use
  • Acronyms ZOMAXEPT
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 11 May 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrial.gov.
    • 18 Nov 2014 Planned End Date changed from 1 Feb 2018 to 1 Mar 2018 as reported by ClinicalTrial.gov record.
    • 16 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrial.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top